This article analyzes the critical role of AI product owners in healthcare, focusing on FDA regulations, real-world case studies, and the balance between innovation and patient safety for improved out...
Recent evidence shows moderate walking reduces tau buildup and inflammation, slowing Alzheimer’s progression. Epidemiological studies highlight dose-response benefits for accessible preventive h...
Recent studies show adipose-derived stem cells with β-tricalcium phosphate scaffolds boost bone regeneration, offering faster healing and lower costs for aging populations. A new therapy using stem c...
Analysis of initiatives like RADIANT-CERSI that help startups navigate SaMD and AIaMD regulations, reducing costs and speeding market entry with real case studies. Programs like RADIANT-CERSI provide ...
This article analyzes how AI product owners in healthcare balance innovation with accountability, using real-world examples like FDA clearances and Epic integrations to ensure patient safety and ethic...
Recent research highlights how neutrophil extracellular traps (NETs) drive chronic inflammation and vascular aging, with NET inhibitors like DNase I and PAD4 antagonists showing potential in reducing ...
The shift from stem cell transplants to extracellular vesicles offers enhanced stability, easier storage, and scalable production, potentially improving treatment accessibility for conditions like Alz...
Recent research shows neutrophil extracellular traps accelerate vascular aging by promoting inflammation and endothelial damage, with NET inhibitors offering promising anti-aging therapies for cardiov...
Extracellular vesicles from stem cells offer a safer alternative to transplants for Alzheimer’s and Parkinson’s, reducing neuroinflammation and promoting repair with promising preclinical ...
Excessive neutrophil extracellular traps (NETs) promote chronic inflammation and endothelial dysfunction, increasing risks for atherosclerosis and stroke, with recent research highlighting inhibitors ...
